NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 119)
Posted On: 02/04/2019 4:54:38 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Featured on Uptick Newswire
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and related services for the global life sciences industry, today announced that its president and CEO, Richard T. Schumacher, was featured on the Uptick Newswire Stock Day Podcast with Everett Jolly. During the interview, Schumacher discussed the company’s recently-announced collaboration with NutraFuels Inc., the commercial launch of its BioPharmaceuticals contract services business and the publication of over 20 scientific papers on PBIO’s unique pressure-based products throughout 2018.
“We are a time-tested company with patents, products, a tremendous customer base, an expanding market, and increasing sales,” Schumacher stated in the interview. “We have struggled a bit over the past few years for a number of different reasons, but we believe we are past that now and on the road to success. Our three pressure-based technology platforms have been vetted by key opinion leaders globally, we have a number of leading scientists in the world who are using our various products, and we expect increased revenue in 2019 from our two new platform technologies (Barofold and UST). We believe that PBIO shareholders have much to be excited about going forward.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and related services for the global life sciences industry, today announced that its president and CEO, Richard T. Schumacher, was featured on the Uptick Newswire Stock Day Podcast with Everett Jolly. During the interview, Schumacher discussed the company’s recently-announced collaboration with NutraFuels Inc., the commercial launch of its BioPharmaceuticals contract services business and the publication of over 20 scientific papers on PBIO’s unique pressure-based products throughout 2018.
“We are a time-tested company with patents, products, a tremendous customer base, an expanding market, and increasing sales,” Schumacher stated in the interview. “We have struggled a bit over the past few years for a number of different reasons, but we believe we are past that now and on the road to success. Our three pressure-based technology platforms have been vetted by key opinion leaders globally, we have a number of leading scientists in the world who are using our various products, and we expect increased revenue in 2019 from our two new platform technologies (Barofold and UST). We believe that PBIO shareholders have much to be excited about going forward.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼